What does PHARMACIE DE BOUSSOIT do?

PHARMACIE DE BOUSSOIT is a pharmacy in La Louvière. Private Limited, started on 21 March 2011, 1 establishment.

What is the address of PHARMACIE DE BOUSSOIT?

The registered office of PHARMACIE DE BOUSSOIT is located at Rue Grande(BO) 186, 7110 La Louvière.

Is PHARMACIE DE BOUSSOIT still active?

Yes. According to the CBE (19 September 2026) PHARMACIE DE BOUSSOIT is active, legal situation “Normale toestand”, started on 21 March 2011.

Is PHARMACIE DE BOUSSOIT registered on Peppol?

Yes, PHARMACIE DE BOUSSOIT is registered on the Peppol network with ID 0208:0834774476.

What is the enterprise number of PHARMACIE DE BOUSSOIT?

The enterprise number of PHARMACIE DE BOUSSOIT is BE0834774476.

When was PHARMACIE DE BOUSSOIT founded?

PHARMACIE DE BOUSSOIT was founded on 21 March 2011.

Is PHARMACIE DE BOUSSOIT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 March 2011; 5 annual accounts filed, latest fiscal year 2025.

How much profit did PHARMACIE DE BOUSSOIT make in 2025?

PHARMACIE DE BOUSSOIT recorded a loss after taxes of € 22,339 in financial year 2025.

What is the revenue of PHARMACIE DE BOUSSOIT?

As a small company, PHARMACIE DE BOUSSOIT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 119,641.

How much does an employee at PHARMACIE DE BOUSSOIT earn?

The average wage cost per full-time employee at PHARMACIE DE BOUSSOIT was € 44,500 in 2023: staff costs of € 53,368 for 1.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

PHARMACIE DE BOUSSOIT (Private Limited) - La Louvière

Dossier PHARMACIE DE BOUSSOIT, printed on 19 September 2026 from databakkes.be/en/0834774476/pharmacie-de-boussoit. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DE BOUSSOIT from La Louvière, company number BE0834774476, closed financial year 2025 with a result of € -22,339 after tax. For that financial year PHARMACIE DE BOUSSOIT recorded a gross margin of € 119,641 and equity of € 228,964. Compared with financial year 2024, the result moved from € 31,112 to € -22,339. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 228,964

▼ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -22,339

▼ still € 31,112 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 37,368

▼ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 216,564.

People and assets in 2025

Wage cost

€ 95,482

▲ 35% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 17,332

▼ 40% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 23,582

▼ 56% vs 2024

€ 15,473 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 80,847

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,321

▼ 34% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 152,104 Gross margin 2022: € 152,104 First fiscal year in the series	€ 147,790 Gross margin 2023: € 147,790 ▼ 3% vs 2022 (€ 152,104) Unfavourable step	€ 166,599 Gross margin 2024: € 166,599 ▲ 13% vs 2023 (€ 147,790) Favourable step	€ 119,641 Gross margin 2025: € 119,641 ▼ 28% vs 2024 (€ 166,599) Unfavourable step	▼ 28%
Profit after taxes	€ 56,728 Profit after taxes 2022: € 56,728 First fiscal year in the series	€ 33,302 Profit after taxes 2023: € 33,302 ▼ 41% vs 2022 (€ 56,728) Unfavourable step	€ 31,112 Profit after taxes 2024: € 31,112 ▼ 7% vs 2023 (€ 33,302) Unfavourable step	€ -22,339 Profit after taxes 2025: € -22,339 ▼ € 53,451 vs 2024 (€ 31,112) Unfavourable step	▼ € 53,451
Equity	€ 186,890 Equity 2022: € 186,890 First fiscal year in the series	€ 220,192 Equity 2023: € 220,192 ▲ 18% vs 2022 (€ 186,890) Favourable step	€ 251,304 Equity 2024: € 251,304 ▲ 14% vs 2023 (€ 220,192) Favourable step	€ 228,964 Equity 2025: € 228,964 ▼ 9% vs 2024 (€ 251,304) Unfavourable step	▼ 9%
Total debts	€ 290,498 Total debts 2022: € 290,498 First fiscal year in the series	€ 197,505 Total debts 2023: € 197,505 ▼ 32% vs 2022 (€ 290,498) Favourable step	€ 153,807 Total debts 2024: € 153,807 ▼ 22% vs 2023 (€ 197,505) Favourable step	€ 120,962 Total debts 2025: € 120,962 ▼ 21% vs 2024 (€ 153,807) Favourable step	▼ 21%
Cash	€ 48,352 Cash 2022: € 48,352 First fiscal year in the series	€ 42,701 Cash 2023: € 42,701 ▼ 12% vs 2022 (€ 48,352) Unfavourable step	€ 41,847 Cash 2024: € 41,847 ▼ 2% vs 2023 (€ 42,701) Unfavourable step	€ 37,368 Cash 2025: € 37,368 ▼ 11% vs 2024 (€ 41,847) Unfavourable step	▼ 11%
Land & buildings	€ 168,734 Land & buildings 2022: € 168,734 First fiscal year in the series	€ 144,957 Land & buildings 2023: € 144,957 ▼ 14% vs 2022 (€ 168,734) Unchanged	€ 118,914 Land & buildings 2024: € 118,914 ▼ 18% vs 2023 (€ 144,957) Unchanged	€ 92,928 Land & buildings 2025: € 92,928 ▼ 22% vs 2024 (€ 118,914) Unchanged	▼ 22%
Retained profit	€ 174,490 Retained profit 2022: € 174,490 First fiscal year in the series	€ 207,792 Retained profit 2023: € 207,792 ▲ 19% vs 2022 (€ 174,490) Favourable step	€ 238,904 Retained profit 2024: € 238,904 ▲ 15% vs 2023 (€ 207,792) Favourable step	€ 216,564 Retained profit 2025: € 216,564 ▼ 9% vs 2024 (€ 238,904) Unfavourable step	▼ 9%
Bank debt	€ 131,065 Bank debt 2022: € 131,065 First fiscal year in the series	€ 92,502 Bank debt 2023: € 92,502 ▼ 29% vs 2022 (€ 131,065) Favourable step	€ 53,177 Bank debt 2024: € 53,177 ▼ 43% vs 2023 (€ 92,502) Favourable step	€ 23,582 Bank debt 2025: € 23,582 ▼ 56% vs 2024 (€ 53,177) Favourable step	▼ 56%
Balance sheet total	€ 477,388 Balance sheet total 2022: € 477,388 First fiscal year in the series	€ 417,698 Balance sheet total 2023: € 417,698 ▼ 13% vs 2022 (€ 477,388) Unchanged	€ 405,110 Balance sheet total 2024: € 405,110 ▼ 3% vs 2023 (€ 417,698) Unchanged	€ 349,927 Balance sheet total 2025: € 349,927 ▼ 14% vs 2024 (€ 405,110) Unchanged	▼ 14%
Employees (FTE)	1.1 Employees (FTE) 2022: 1.1 First fiscal year in the series	1.2 Employees (FTE) 2023: 1.2 ▲ 0.1 vs 2022 (1.1) Unchanged	-	-

Key figures of PHARMACIE DE BOUSSOIT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DE BOUSSOIT?

What happened at PHARMACIE DE BOUSSOIT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 22,339 (▼ € 53,451 vs 2024). filed late Source: NBB ↗
Apr 1, 2011 New establishment in La Louvière. KBO
Mar 21, 2011 Start of the company according to the CBE. KBO

In short

From € 56,728 profit in 2022 to € 22,339 loss in 2025.

Paid € 56,959 in corporate taxes since 2022.

Best year ever: 2022, with € 56,728 profit.

On average € 123,200 of value added per employee in 2023.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DE BOUSSOIT? We notify you, reason included.

Follow PHARMACIE DE BOUSSOIT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Grande(BO) 186

7110 La Louvière

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0834.774.476

VAT number

BE 0834.774.476

Registered office

Rue Grande(BO) 186, 7110 La Louvière

Names & denominations

PHARMACIE DE BOUSSOIT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 March 2011

Peppol

Active · Active since 28 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗